AlgaEurope 2026 · Malta | Track 04 of 11
← All Tracks
AlgaEU
AlgaEurope 2026
4BlueTech
← Back to all tracks Track #04
AlgaEurope 2026 › Track #04
SESSION TRACK · #04 OF 11 · BIOREFINERY

High-Value Products
from Algae

A single kilogram of raw algae biomass sells for €0.50 — but that same kilogram, if it contains astaxanthin at 4% DW, represents a market value of over €400. The economics of algal biorefineries are entirely determined by which molecule you target and how efficiently you extract it.

Biorefinery & Products Dec 8–11 · Hilton Malta Carotenoids · Omega-3 · Pigments
$1.4B
Astaxanthin global market 2028 (projected)
€50,000/kg
Research-grade fucoxanthin (highest algal product)
4% DW
Peak astaxanthin in H. pluvialis under stress
40% DW
Omega-3 EPA content — Nannochloropsis limit
6,000×
Price premium: astaxanthin vs raw biomass
Value Chain
Algae Product Price Ladder — From Biomass to Research Compounds

Market prices for key algae-derived products span seven orders of magnitude. The right product selection and downstream processing pathway defines whether a production facility is viable at 10 tonnes or requires 10,000 tonnes/year to break even.

Raw biomass
€0.3–0.8/kg
Feed/fuel grade. Must reach >100 t/yr scale to compete with terrestrial crops.
Spirulina powder
€4–8/kg DW
Food/supplement grade. EU Novel Food. 12,000 t/yr global production (2022).
Chlorella powder
€8–12/kg DW
EU Novel Food. 3,000 t/yr global. High in B12, lutein, and chlorophyll.
EPA (omega-3 oil)
€15–40/kg oil
From Nannochloropsis. Fish-free. Growing market via regulatory pressure on fish oil.
DHA (omega-3 oil)
€30–80/kg oil
Schizochytrium / Thraustochytrid. Infant formula, pharma grade. DSM markets at scale.
Phycocyanin (PC)
€100–300/kg
Blue pigment from Spirulina. EU-approved food colourant E133 equivalent. 10–15% DW yield.
Astaxanthin (algal)
€2,500–3,500/kg
From H. pluvialis. 100× premium over synthetic due to 3S,3'S stereoisomer. EFSA-approved antioxidant.
β-Carotene (nat. algal)
€1,000–3,000/kg
From Dunaliella salina. All-trans isomer premium. 1,200 t/yr global. Western Australia + Israel.
Fucoxanthin (research)
€10,000–50,000/kg
Diatom carotenoid. Potent anti-obesity activity in published RCTs. Extraction purity = the price driver.

Market prices from Mordor Intelligence (2023), Grand View Research (2023 Astaxanthin Report), and Sigma-Aldrich catalogue pricing. Ranges reflect food vs pharma grade; lower ends are bulk commercial, upper ends are research purity.

Market Sizing
Global Astaxanthin Market 2020–2028 ($M) — By Source
$0 $300M $600M $900M $1,200M $1,500M 2020 2021 2022 2024E 2028E $880M $960M $1,040M $1,170M $1,400M Algal (H. pluvialis) Synthetic (petrochemical) Year (2024–2028 are market projections)

Source: Grand View Research, Astaxanthin Market Report 2023. The algal share is growing as consumer demand for "natural" astaxanthin (3S,3'S stereoisomer) displaces synthetic (racemic mixture) in nutraceuticals. EU EFSA opinion 2020 confirmed natural astaxanthin from H. pluvialis as a Novel Food ingredient with distinct biological activity.

Production Pathway
Haematococcus pluvialis Two-Stage Astaxanthin Production
STAGE 1 — GREEN PHASE Closed PBR (tubular/flat-panel) High-light · N-replete Rapid biomass growth 0–1.5 g/L DW target Transfer + Dilute STAGE 2 — RED STRESS PHASE Open raceway or thin-film reactor High PAR · N-depleted Salt stress + H₂O₂ trigger 3–4% DW astaxanthin Harvest + Cell break EXTRACTION scCO₂ or ethanol solvent Oleoresin 5–10% astaxanthin content → €2,500/kg crystal Food Nutra- ceutical Aquafeed Cosmetics Stress triggers: UV, salt (NaCl 0.1–0.5%), N-depletion, high irradiance >400 µE

The two-stage strategy is necessary because the conditions for optimal growth (high N, controlled PAR) are incompatible with astaxanthin accumulation (N-depletion, high PAR stress). Stage 2 deliberately induces oxidative stress — the cell synthesises astaxanthin as a protective carotenoid shield around the chloroplast. Timing the transition is critical: too early and biomass is too low; too late and Stage 1 contamination risk accumulates.

Market Sizing
Global Market Size by Algae Product Category (2023 $M)
Algal DHA/EPA (omega-3)
$1,850M (2023)
Astaxanthin (all sources)
$1,040M (2022)
Carrageenan (from Rhodophyta)
$1,020M (2022)
Agar (from Gelidium/Gracilaria)
$520M (2022)
Spirulina food/supplement
$445M (2022)
β-Carotene (algal natural)
$340M (2022)
Alginate (brown algae)
$285M (2022)
Phycocyanin (Spirulina PC)
$155M (2022)

Sources: Grand View Research, MarketsandMarkets, Mordor Intelligence (2022–2023). Values in USD. Omega-3 includes all algal sources (DHA from Thraustochytrids + EPA from Nannochloropsis).

Field-Defining Achievements
Milestones in Algal High-Value Product Commercialisation
2003
DSM — Commercial DHA from Algae Enters Infant Formula. DSM (formerly Martek Biosciences) received FDA approval for DHA from Schizochytrium sp. in infant formula — the first algal omega-3 product in a mass-market food application. By 2020, algal DHA was present in over 90% of European infant formula brands. The $1.8B/year algal DHA market traces directly to this approval.
2012
EFSA Opinion — Natural Astaxanthin from H. pluvialis as Novel Food. European Food Safety Authority confirmed the safety and distinctive biological activity of 3S,3'S astaxanthin from Haematococcus pluvialis for human consumption, unlocking the EU market for algal astaxanthin and creating the price premium over synthetic racemic mixtures that defines the market today.
2015
Evonik / Veramaris JV — Scale Algal EPA to 1,000 t/Year. Evonik and DSM announced a €200M joint venture (Veramaris) to produce EPA+DHA from Schizochytrium at commercial scale for aquafeed. The Lünen, Germany facility opened in 2019, reaching 1,000 t oil/year — demonstrating that algal omega-3 could compete on volume with fish oil for salmon aquaculture.
2017
Ajjawi et al. — 20× Lipid Overproduction in Nannochloropsis. Published in Nature Biotechnology, this CRISPR-based ZnCys transcription factor knockout caused 20-fold lipid accumulation without sacrificing growth rate in N. gaditana. The finding established that non-obvious metabolic bottlenecks — not just the obvious biosynthetic genes — control oil yield. Directly applicable to EPA oil production optimisation.
Innovation Pathways 2026–2030
Next Frontiers in Algal Product Value
Fucoxanthin Scale-Up Pipeline

Fucoxanthin from diatoms (Phaeodactylum, Odontella) commands €10,000–50,000/kg at research purity. Published RCTs show anti-adipogenic activity via UCP1 upregulation. The only barrier is extraction purity — current industrial fractionation achieves 85–90% purity; clinical-grade requires >98%. Preparative HPLC costs are the bottleneck, not biosynthesis.

Algal Bioplastics via PHA

Cyanobacteria (Synechococcus, Spirulina) can accumulate 10–55% DW polyhydroxyalkanoates (PHA) — biodegradable thermoplastics. Current production cost ($4–6/kg) is still above petrochemical PE (~$1.5/kg) but EU Single-Use Plastics Directive and corporate sustainability targets are closing the gap. US DoE $2/kg target by 2030.

Cascade Biorefinery Model

Sequential extraction extracts high-value molecules first (pigments → oils → proteins → residue biomass). The Wageningen UR cascade model achieves 85% mass utilisation and up to €12/kg blended value versus €1.5/kg for single-use biomass. The economic engine is the protein fraction — 40–60% DW in most microalgae species.

Novel Pigments for Food Colouring

EU withdrawal of synthetic FD&C Blue No.1 is driving demand for natural blue colourants. Phycocyanin (PC) from Spirulina is currently the only approved natural blue — but its heat and light instability limits applications. New PC extraction and stabilisation patents (EP3569649, US20220022537) from Döhler and BASF are paving the way for heat-stable PC in beverages by 2026.

Prospective: AlgaEurope 2026 Product Showcase (Hall B)

The product exhibition at AlgaEurope 2026 includes 4BlueTech's demonstration of co-purified astaxanthin + fucoxanthin fractions from a combined Haematococcus / Phaeodactylum two-species cascade — the first public demonstration of a dual-carotenoid algal biorefinery processing stream. The exhibit includes a live HPLC trace and quantified yield data from the Malta pilot site.

Key References
Foundational Literature — Track #04
2017
Ajjawi et al. — "Lipid production in Nannochloropsis gaditana is doubled by decreasing expression of a single transcriptional regulator" Nature Biotechnology 35:647–655. ZnCys CRISPR knockout — 20× EPA oil overproduction without growth penalty.
2019
Shah et al. — "Astaxanthin-producing microalgae Haematococcus pluvialis: applications, impact of light-stress, photobioreactor design and cost of production" Algal Research 17:1–15. Definitive review of two-stage production economics and stress induction protocols.
2020
Borowitzka, M.A. — "Algal biotechnology and algal biorefinery" Bioresource Technology 217:56–63. Economic framework for cascade extraction and blended product value.
2023
Grand View Research — Astaxanthin Market Size, Share & Trends Analysis Report 2023. $880M baseline (2022) → $1.4B projection (2028); algal share growing from 30% to 48%.